These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4004 related articles for article (PubMed ID: 8687112)

  • 21. Efficient transplantation of human non-T-leukemia cells into nude mice and induction of complete regression of the transplanted distinct tumors by ricin A-chain conjugates of monoclonal antibodies SN5 and SN6.
    Hara H; Luo Y; Haruta Y; Seon BK
    Cancer Res; 1988 Aug; 48(16):4673-80. PubMed ID: 2969282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoclonal antibody therapy of cancer.
    Weiner LM
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):43-51. PubMed ID: 10561017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer?
    Zöller M; Matzku S
    Arch Immunol Ther Exp (Warsz); 2002; 50(3):197-224. PubMed ID: 12098935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Monoclonal antibodies in the diagnosis and therapy of lung cancer].
    Campobasso N; Dammacco F
    Recenti Prog Med; 1991 Dec; 82(12):642-51. PubMed ID: 1667710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies in the treatment of hematopoietic malignancies.
    Houghton A; Scheinberg D
    Semin Hematol; 1988 Jul; 25(3 Suppl 3):23-9. PubMed ID: 3051406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
    Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy with bispecific antibodies.
    Thielemans KM
    Verh K Acad Geneeskd Belg; 1995; 57(3):229-47; discussion 247-8. PubMed ID: 7483816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The new face of bispecific antibodies: targeting cancer and much more.
    Lum LG; Davol PA; Lee RJ
    Exp Hematol; 2006 Jan; 34(1):1-6. PubMed ID: 16413384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
    Hwang C; Sanda MG
    Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New approaches to antibody therapy.
    Weiner LM; Adams GP
    Oncogene; 2000 Dec; 19(53):6144-51. PubMed ID: 11156528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade.
    Weber J
    Semin Oncol; 2010 Oct; 37(5):430-9. PubMed ID: 21074057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunotherapy of tumors of the central nervous system].
    Monod L; Sawamura Y; De Tribolet N
    Neurochirurgie; 1992; 38(2):69-79. PubMed ID: 1603233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental immunotherapy of human breast carcinomas implanted in nude mice with a mixture of monoclonal antibodies against human milk fat globule components.
    Ceriani RL; Blank EW; Peterson JA
    Cancer Res; 1987 Jan; 47(2):532-40. PubMed ID: 3791239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
    Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
    Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotherapy of ovarian cancer.
    Lidor Y; Bast RC
    Nat Immun Cell Growth Regul; 1988; 7(4):193-215. PubMed ID: 3070370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibodies in the treatment of lung cancer.
    Egri G; Takáts A
    Eur J Surg Oncol; 2006 May; 32(4):385-94. PubMed ID: 16504454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marked difference in the in vivo antitumor efficacy between two immunotoxins targeted to different epitopes of common acute lymphoblastic leukemia antigen (CD10). Mechanisms involved in the differential activities of immunotoxins.
    Luo Y; Seon BK
    J Immunol; 1990 Sep; 145(6):1974-82. PubMed ID: 1697314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 201.